APA (7th ed.) Citation

Sorasak Intorasoot, Amornrat Intorasoot, Arocha Tawteamwong, Bordin Butr-Indr, Ponrut Phunpae, Chayada Sitthidet Tharinjaroen, . . . Jiaranai Khantipongse. (2022). <i>In Vitro</i> Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, against Susceptible and Drug-Resistant <i>Mycobacterium tuberculosis</i> and Its Synergistic Effect with Rifampicin. MDPI AG.

Chicago Style (17th ed.) Citation

Sorasak Intorasoot, Amornrat Intorasoot, Arocha Tawteamwong, Bordin Butr-Indr, Ponrut Phunpae, Chayada Sitthidet Tharinjaroen, Usanee Wattananandkul, Sirikwan Sangboonruang, and Jiaranai Khantipongse. <i>In Vitro</i> Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, Against Susceptible and Drug-Resistant <i>Mycobacterium Tuberculosis</i> and Its Synergistic Effect with Rifampicin. MDPI AG, 2022.

MLA (9th ed.) Citation

Sorasak Intorasoot, et al. <i>In Vitro</i> Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, Against Susceptible and Drug-Resistant <i>Mycobacterium Tuberculosis</i> and Its Synergistic Effect with Rifampicin. MDPI AG, 2022.